首页 > 市场调查报告书 > 医疗设备

生技设备基因治疗学和RNAi

市场调查报告书

商品编码

1407314

基因分型市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、技术、按应用、最终用途、地区和竞争细分

Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technology, By Application, By End Use, By Region, and By Competition

出版日期: 2023年11月07日 | 出版商:

TechSci Research | 英文 176 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2022 年全球基因分型市场价值为 150.1 亿美元，预计到 2028 年预测期内将出现令人瞩目的成长，复合CAGR为8.26%。全球基因分型市场是生物技术和生命科学领域一个充满活力且快速成长的领域。基因分型是一种确定个别基因组成（包括 DNA 序列变异）的过程。这些资讯对于从个人化医学和疾病研究到农业和血统测试的广泛应用至关重要。

主要市场驱动因素

基因分型技术的进步

市场概况
预测期	2024-2028
2022 年市场规模	150.1亿美元
2028 年市场规模	239.3亿美元
2023-2028 年CAGR	8.26%
成长最快的细分市场	製药与生物技术公司
最大的市场	北美洲

由于基因分型技术的进步，基因分型（分析个体基因组成的过程）正在经历一场革命。这些创新不仅提高了基因分型的效率和准确性，而且还将其应用扩展到各个领域，包括医疗保健、研究、农业和个人化医疗。

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按地区
- 按公司划分 (2022)
产品市场地图
- 按产品分类
- 依技术
- 按应用
- 按最终用途
- 按地区

第 6 章：北美基因分型市场展望

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按国家/地区
北美：国家分析
- 美国
- 加拿大
- 墨西哥

第 7 章：欧洲基因分型市场展望

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按国家/地区
欧洲：国家分析
- 德国
- 英国
- 法国
- 义大利
- 西班牙

第 8 章：亚太地区基因分型市场展望

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按国家/地区
亚太地区：国家分析
- 中国
- 日本
- 印度
- 澳洲
- 韩国

第 9 章：南美洲基因分型市场展望

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按国家/地区
南美洲：国家分析
- 巴西
- 阿根廷
- 哥伦比亚

第 10 章：中东和非洲基因分型市场展望

市场规模及预测
- 按价值
市占率及预测
- 按产品（仪器、试剂和套件、软体和服务）
- 依技术（PCR、毛细管电泳、微阵列、定序、质谱等）
- 按应用（药物基因组学、诊断和个人化医疗、农业生物技术、动物遗传学、其他）
- 依最终用途（製药和生物製药公司、诊断和研究实验室、学术机构等）
- 按国家/地区
MEA：国家分析
- 南非基因分型
- 沙乌地阿拉伯基因分型
- 阿联酋基因分型
- 科威特基因分型

第 11 章：市场动态

司机
挑战

第 12 章：市场趋势与发展

近期发展
併购
产品发布

第 13 章：波特的五力分析

产业竞争
新进入者的潜力
供应商的力量
客户的力量
替代产品的威胁

第14章：竞争格局

商业概览
产品供应
最近的发展
财务（据报导）
主要人员
SWOT分析
- Thermo Fisher Scientific Inc
- Illumina Inc
- QIAGEN NV
- F Hoffmann-La Roche AG
- Danaher Corp
- Agilent Technologies Co Ltd
- Eurofins Scientific Inc
- GE Healthcare Inc
- Bio-Rad Laboratories Inc

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录

Product Code: 20651

Global Genotyping Market has valued at USD 15.01 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.26% through 2028. The global genotyping market is a dynamic and rapidly growing sector within the field of biotechnology and life sciences. Genotyping is the process of determining an individual's genetic makeup, including variations in their DNA sequence. This information is crucial for a wide range of applications, from personalized medicine and disease research to agriculture and ancestry testing.

Key Market Drivers

Advancements in Genotyping Technologies

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 15.01 Billion
Market Size 2028	USD 23.93 Billion
CAGR 2023-2028	8.26%
Fastest Growing Segment	Pharmaceutical & Biotechnology Companies
Largest Market	North America

Genotyping, the process of analyzing an individual's genetic makeup, is undergoing a revolution thanks to advancements in genotyping technologies. These innovations have not only enhanced the efficiency and accuracy of genotyping but also expanded its applications across various sectors, including healthcare, research, agriculture, and personalized medicine.

One of the most significant factors propelling the genotyping market forward is the advent of high-throughput genotyping platforms. These platforms can analyze thousands or even millions of genetic markers in a single experiment, significantly increasing the speed and cost-effectiveness of genotyping. Researchers and clinicians can process larger datasets quickly, making genotyping accessible for a wide range of applications.

Next-generation sequencing, or NGS, is a game-changer in genotyping. It allows for the simultaneous sequencing of a person's entire genome, making it possible to identify even the rarest genetic variations. NGS is not only faster and more affordable than traditional Sanger sequencing, but it also generates vast amounts of data, enabling comprehensive genomic analysis. This technology has become essential in research, clinical diagnostics, and personalized medicine.

Advancements in genotyping technologies have significantly improved the accuracy and resolution of genotyping results. Single nucleotide polymorphism (SNP) genotyping, for example, has become highly accurate, making it an invaluable tool in identifying genetic markers associated with diseases, drug responses, and other traits. This precision has bolstered the credibility of genotyping in both research and clinical applications.

Miniaturization of genotyping processes and the ability to multiplex, or analyze multiple genetic markers simultaneously, have streamlined genotyping workflows. This has led to a reduction in the amount of sample required, lower reagent costs, and shorter turnaround times. These advancements make genotyping accessible to a broader range of users, from small laboratories to high-throughput facilities.

Modern genotyping technologies offer greater customization and flexibility. Researchers and clinicians can tailor their genotyping assays to specific genetic markers of interest, which is particularly valuable when studying rare diseases or specific population groups. This customization has opened up new possibilities in genotyping research and diagnostics.

As genotyping technologies continue to advance, their applications are expanding. In addition to medical diagnostics and research, genotyping is becoming crucial in fields like agriculture, where it's used to improve crop breeding and animal husbandry. The proliferation of consumer genotyping services for ancestry testing is also boosting the market's growth.

The influx of data generated by advanced genotyping technologies necessitates robust bioinformatics tools for data analysis and interpretation. This has spurred innovation in the field of bioinformatics, allowing researchers and clinicians to derive meaningful insights from genetic data. The synergy between advanced genotyping technologies and sophisticated data analysis tools is a driving force behind the market's growth.

Pharmacogenomics

Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, has emerged as a powerful force driving the growth of the global genotyping market. As the healthcare industry moves toward personalized medicine, the role of pharmacogenomics is becoming increasingly significant.

One of the key drivers behind the growth of the global genotyping market is the shift towards personalized medicine. Healthcare providers are increasingly recognizing that "one-size-fits-all" drug prescriptions may not be effective for every patient. By analyzing an individual's genetic variations, pharmacogenomics enables the customization of drug therapies to match the patient's unique genetic profile. This approach not only improves treatment outcomes but also reduces the risk of adverse drug reactions.

Pharmacogenomics relies on identifying specific genetic markers or variants that are associated with an individual's drug response. Genotyping plays a pivotal role in this process by detecting these genetic variations. As our understanding of these markers deepens, more genes are being identified as having an impact on drug metabolism, efficacy, and safety. This knowledge fuels the demand for genotyping to assess these genetic markers in patients.

Adverse drug reactions (ADRs) are a significant concern in healthcare, often leading to increased healthcare costs and patient harm. Pharmacogenomics, enabled by genotyping, can help predict the likelihood of ADRs based on a patient's genetic profile. By adjusting drug dosages or selecting alternative medications that are better suited to a patient's genetic makeup, healthcare providers can significantly reduce the risk of ADRs. This, in turn, reduces the overall healthcare burden and enhances patient safety.

The identification of genetic markers associated with drug responses has given rise to the development of targeted therapies. These therapies are designed to address the specific genetic underpinnings of a disease. Genotyping is crucial for selecting patients who are most likely to benefit from these therapies, ensuring they receive the most effective and tailored treatment.

Pharmacogenomics and genotyping are also transforming the drug discovery and development process. Pharmaceutical companies can use genetic data to identify potential drug targets, optimize clinical trial designs, and enhance the success rate of new drug candidates. This application has led to increased collaboration between genotyping service providers and the pharmaceutical industry, further expanding the genotyping market.

Pharmacogenomics is steadily finding its place in clinical practice. As guidelines and recommendations for using genetic information in treatment decisions become more widespread, healthcare providers are increasingly adopting genotyping as a routine part of patient care. This integration is driving the demand for genotyping services and products.

Agriculture and Crop Improvement

Agriculture and crop improvement have become critical areas of focus as the global population continues to grow and environmental challenges mount. Genotyping, the process of analyzing an organism's genetic makeup, plays an instrumental role in enhancing crop breeding and livestock management.

As the world's population continues to expand, there is a pressing need to increase agricultural productivity to meet the growing demand for food, feed, and fiber. Sustainable agriculture practices, which aim to optimize resource use and minimize environmental impacts, are gaining prominence. Genotyping plays a pivotal role in achieving these sustainability goals by enabling the development of crops that are more resilient, productive, and resource efficient.

Precision agriculture, often referred to as "smart farming," relies on technology to make agriculture more precise and efficient. Genotyping is a crucial component of precision agriculture. By analyzing the genetic traits of crops, farmers can make data-driven decisions on planting, fertilization, irrigation, and pest control. This helps improve yields and minimize resource waste.

Genotyping is a game-changer in crop breeding. It allows breeders to select for specific genetic traits, such as disease resistance, drought tolerance, and improved yield, with greater precision. By understanding the genetic makeup of plants, breeders can expedite the development of new crop varieties with desired characteristics. Genotyping facilitates faster and more accurate trait selection.

Genotyping is essential for conserving genetic diversity in plant species. As climate change and evolving pests and diseases threaten crop biodiversity, preserving the genetic resources of crops is crucial. Genotyping helps identify and preserve valuable genetic traits, making it possible to develop more robust and adaptable crops.

Plant diseases are a significant threat to agricultural productivity. Genotyping enables researchers to identify genetic markers associated with disease resistance in crops. By breeding for these markers, farmers can cultivate crops that are more resilient to diseases, reducing the need for chemical pesticides.

Ancestry and Genealogy Services

Ancestry and genealogy services have experienced a remarkable surge in popularity as more people seek to uncover their roots and explore their genetic heritage. These services have played a crucial role in driving the growth of the global genotyping market.

The growing consumer interest in genealogy and ancestral heritage has been a primary driver of the genotyping market's growth. Ancestry and genealogy services offer individuals the opportunity to trace their family histories, explore geographic origins, and connect with distant relatives. These services rely on DNA analysis, specifically genotyping, to provide insights into a person's genetic heritage.

The increasing accessibility and affordability of genotyping services have democratized the field of genealogy. Advances in genotyping technologies have made genetic testing more cost-effective and readily available to the general public. This has resulted in a significant expansion of the customer base for genotyping services.

One of the key applications of genotyping in genealogy services is the estimation of an individual's ethnic or geographic ancestry. By analyzing specific genetic markers and comparing them to reference populations, genotyping can provide insights into a person's ethnic background, helping individuals discover their ancestral roots. This feature is a major attraction for users of genealogy services.

Genotyping services have the power to connect family members who were previously unknown to each other. Users can discover long-lost relatives or connect with distant cousins through shared genetic markers. The prospect of finding and connecting with family members, even across borders and continents, adds to the appeal of ancestry and genealogy services.

Genotyping enables the creation of personalized family histories based on genetic data. Users can access comprehensive reports that detail their ancestral migration patterns, genetic predispositions, and historical context. These insights provide a deeper understanding of one's family history, adding a personal touch to the broader story of human migration and evolution.

As more individuals participate in genealogy and ancestry services, DNA databases have grown significantly. These databases house a wealth of genetic information, making them valuable resources for genetic research and scientific studies. This abundance of data further fuels the demand for genotyping services.

Key Market Challenges

Data Management and Interpretation

One of the primary challenges in the genotyping market is the management and interpretation of the massive amounts of genetic data generated. Genotyping technologies, especially high-throughput platforms and next-generation sequencing, produce enormous datasets. The efficient analysis and interpretation of this data requires robust bioinformatics tools and skilled personnel, making data management a significant hurdle.

Standardization

Standardization is a crucial challenge in genotyping. There are various genotyping platforms and methods available, and without standardized protocols, it can be challenging to compare results across different studies and laboratories. Establishing common standards for genotyping assays is essential to ensure data consistency and reliability.

Technological Obsolescence

The genotyping field is continually evolving, with new technologies emerging at a rapid pace. This dynamic environment can lead to challenges in managing existing platforms and keeping up with the latest advancements. Genotyping service providers must adapt to new technologies while still supporting older systems for established customer bases.

Key Market Trends

Integration of Multi-Omics Approaches

Genotyping is increasingly being integrated with other omics technologies such as proteomics and metabolomics. This holistic approach allows researchers to gain a more comprehensive understanding of biological systems. By analyzing genetic, protein, and metabolic data together, researchers can uncover intricate relationships and potential biomarkers for various diseases and conditions.

Single-Cell Genotyping

The ability to analyze the genetic makeup of individual cells is gaining momentum. Single-cell genotyping is revolutionizing our understanding of cellular heterogeneity, offering insights into the genetic diversity within tissues and the development of diseases. This technology has vast potential in fields like cancer research and developmental biology.

CRISPR and Genome Editing

The continued development of CRISPR-Cas9 and other genome editing techniques is expanding the applications of genotyping. Genotyping is essential for confirming the success of gene editing experiments and assessing the specificity and off-target effects of these technologies. This trend is not only applicable in research but also in therapeutic applications.

Segmental Insights

Product Insights

Based on the category of Product, the reagents and kits category dominated in 2022, boasting the largest market share. This segment is poised for a robust CAGR in the upcoming years, primarily driven by the increasing demand for genetic testing, higher investments in research and development, and a surge in genotyping testing volumes.

Furthermore, the software and services segment is expected to experience substantial growth from 2023 to 2030, mainly due to the growing adoption of software-based services by research laboratories and academic institutions. Bioinformatics solutions play a pivotal role in enhancing the effectiveness of sequencing methods and mitigating errors inherent in traditional sequencing techniques. These services find applications across various domains, including agrigenomics, human diseases, animal livestock, and microbes. All these factors are projected to fuel market expansion over the forecast period.

Technology Insights

Based on Technology, the sequencing sector reigned supreme in 2022, and it is poised for substantial growth during the forecast period. This anticipated growth is attributed to its enhanced specificity and superior capacity to detect low-expression and differentially expressed genes compared to alternative techniques. Additionally, genotyping by sequencing offers the advantage of conducting comparative analyses across samples without the necessity of a reference genome.

On the other hand, the PCR (Polymerase Chain Reaction) segment is forecasted to experience a significant CAGR from 2023 to 2030. This projection is driven by an escalating demand for advanced diagnostic methods, the increasing number of Contract Research Organizations (CROs), forensic and research laboratories, as well as the rising prevalence of diseases, including chronic diseases and genetic disorders. These factors are anticipated to be major catalysts for market expansion.

Regional Insights

North America secured the largest market share in 2022, primarily because of the growing adoption of cutting-edge products, the substantial presence of major pharmaceutical and biopharmaceutical companies, proactive government initiatives, and advancements in healthcare infrastructure. Furthermore, the significant presence of key industry players in this region has contributed to its substantial market share.

Conversely, the Asia Pacific region is expected to demonstrate the most rapid CAGR during the forecast period. This is driven by the abundance of untapped opportunities in the region, along with a rising number of clinical trials being conducted. This growth can also be attributed to factors such as technological advancements and the expanding pharmaceutical and biopharmaceutical sector in the region.

Key Market Players

Thermo Fisher Scientific Inc

Illumina Inc

QIAGEN N.V.

F Hoffmann-La Roche AG

Danaher Corp

Agilent Technologies Co Ltd

Eurofins Scientific Inc

GE Healthcare Inc

Bio-Rad Laboratories Inc

Report Scope:

In this report, the Global Genotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genotyping Market, By Product:

Instruments
Reagents & Kits
Software and Services

Genotyping Market, By Technology:

PCR
Capillary Electrophoresis
Microarrays
Sequencing
Mass Spectrometry
Others

Genotyping Market, By Application:

Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others

Genotyping Market, By End Use:

Pharmaceutical and Biopharmaceutical Companies
Diagnostics and Research Laboratories
Academic Institutes
Others

Genotyping Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genotyping Market.

Available Customizations:

Global Genotyping market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genotyping Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 5.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2022)
5.3. Product Market Map
- 5.3.1. By Product
- 5.3.2. By Technology
- 5.3.3. By Application
- 5.3.4. By End Use
- 5.3.5. By Region

6. North America Genotyping Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 6.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 6.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 6.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Genotyping Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End Use
- 6.3.2. Canada Genotyping Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End Use
- 6.3.3. Mexico Genotyping Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End Use

7. Europe Genotyping Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 7.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 7.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 7.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Genotyping Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End Use
- 7.3.2. United Kingdom Genotyping Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End Use
- 7.3.3. France Genotyping Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End Use
- 7.3.4. Italy Genotyping Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End Use
- 7.3.5. Spain Genotyping Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End Use

8. Asia-Pacific Genotyping Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 8.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 8.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 8.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Genotyping Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End Use
- 8.3.2. Japan Genotyping Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End Use
- 8.3.3. India Genotyping Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End Use
- 8.3.4. Australia Genotyping Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End Use
- 8.3.5. South Korea Genotyping Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End Use

9. South America Genotyping Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 9.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 9.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 9.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Genotyping Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End Use
- 9.3.2. Argentina Genotyping Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End Use
- 9.3.3. Colombia Genotyping Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End Use

10. Middle East and Africa Genotyping Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
- 10.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
- 10.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
- 10.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Genotyping Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End Use
- 10.3.2. Saudi Arabia Genotyping Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End Use
- 10.3.3. UAE Genotyping Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End Use
- 10.3.4. Kuwait Genotyping Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Product
    - 10.3.4.2.2. By Technology
    - 10.3.4.2.3. By Application
    - 10.3.4.2.4. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
- 14.6.1. Thermo Fisher Scientific Inc
- 14.6.2. Illumina Inc
- 14.6.3. QIAGEN N.V.
- 14.6.4. F Hoffmann-La Roche AG
- 14.6.5. Danaher Corp
- 14.6.6. Agilent Technologies Co Ltd
- 14.6.7. Eurofins Scientific Inc
- 14.6.8. GE Healthcare Inc
- 14.6.9. Bio-Rad Laboratories Inc